US Patent Issued to MINDRANK AI on Aug. 4 for "Aryl ether-substituted heterocyclic compounds as GLP1R agonists" (Chinese Inventors)

ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,698,270, issued on Aug. 4, was assigned to MINDRANK AI LTD. (Hangzhou, China).

"Aryl ether-substituted heterocyclic compounds as GLP1R agonists" was invented by Long Zhang (Hangzhou, China), Zhangming Niu (Hangzhou, China) and Bowen Tang (Hangzhou, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "A novel aryl ether substituted heterocyclic compound has GLP1R agonist activity. A GLP1R agonist is represented by formula (I), or a pharmaceutically acceptable salt, solvate, hydrate, isotope substituent or isomer thereof."

The patent was filed on Jan. 31, 2022, under Application No. 18/255,247.

*For further information, including images, charts and table...